絞り込み

16767

広告

Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center.

著者 Nannoni S , Strambo D , Sirimarco G , Amiguet M , Vanacker P , Eskandari A , Saliou G , Wintermark M , Dunet V , Michel P
J Neurointerv Surg.2019 Nov 26 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1view , 0users)

Full Text Sources

The real-life application of DAWN and DEFUSE-3 trials has been poorly investigated. We aimed to identify the proportion of patients with acute ischemic stroke (AIS) eligible for late endovascular treatment (EVT) in our stroke center based on trial and more liberal selection criteria.
PMID: 31772044 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード